As discussed above, with ESCC, lower DSC2 levels cause PG to compete with β-Catenin when binding to E-Cadherin, thus leading to the altered functioning of adherens junctions [8]. This evidence concerns the gene DSC2 and esophageal squamous cell carcinoma.